The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Open accessAbstract
We investigated SARS-CoV-2 potential tropism by surveying expression of viral entry-associated genes in single-cell RNA-sequencing data from multiple tissues from healthy human donors. We co-detected these transcripts in specific respiratory, corneal and intestinal epithelial cells, potentially explaining the high efficiency of SARS-CoV-2 transmission. These genes are co-expressed in nasal epithelial cells with genes involved in innate immunity, highlighting the cells’ potential role in initial viral infection, spread and clearance. The study offers a useful resource for further lines of inquiry with valuable clinical samples from COVID-19 patients and we provide our data in a comprehensive, open and user-friendly fashion at www.covid19cellatlas.org . An analysis of single-cell transcriptomics datasets from different tissues shows that ACE2 and TMPRSS2 are co-expressed in respiratory, corneal and intestinal epithelial cell populations, and that respiratory expression of ACE2 is associated with genes involved in innate immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although scSeq revealed ACE2 transcripts in only a subset of OE cells, this low level of observed expression matches or exceeds that observed in respiratory cells types that are infected by CoV-2 in COVID-19 patients (39) (Fig. 3).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [39]
Experimental — accuracy not yet measuredIn the citing paper
“Probably most important for the high efficacy of SARS-CoV-2 transmission is the high co-expression of ACE2 and TMPRSS2 in nasal epithelial cells, particularly in two types of goblet cells and a subset of ciliated cells, showing the highest expression among all cells in the respiratory tree (Figure 2 A).”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“An interesting observation of this study was the high co-expression of genes involved in early steps of antiviral immune responses in these epithelial cells, which indicated the potential for these specialized nasal cells to play an important role in the initial viral infection, spread, but potentially also, clearance.”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“TMPRSS2 is more widely expressed than ACE2, and cells with simultaneous expression were identified in the respiratory tree, the cornea, esophagus, ileum, colon, gallbladder, and common bile duct (Sungnak et al., 2020), yet there was no evidence for simultaneous expression in immune cells.”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“It has recently been demonstrated through single cell RNA sequencing analysis (referred to herein as scSeq) that cells from the human upper airway — including nasal RE goblet and ciliated cells —express high levels of ACE2 and TMPRSS2, suggesting that these RE cell types may serve as a viral reservoir during CoV-2 infection (39, 40).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Clinical Characteristics of Coronavirus Disease 2019 in China
Eastin, C., & Eastin, T. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.004 · Cited by 24,945
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Fast, sensitive and accurate integration of single-cell data with Harmony
Korsunsky, I., Millard, N., Fan, J., Slowikowski, K., Zhang, F., Wei, K., Baglaenko, Y., Brenner, M., Loh, P.-R., & Raychaudhuri, S. (2019) · Nature Methods · doi:10.1038/s41592-019-0619-0 · Cited by 10,488
Cited by
Sorted by citations
Items 201–300 of 1,000
From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants
PAPANIKOLAOU, V. S., Chrysovergis, A., Ragos, V., Tsiambas, E., Katsinis, S., Manoli, A., Papouliakos, S. M., Roukas, D., Mastronikolis, S. N., Peschos, D., et al. (2022) · Gene · doi:10.1016/j.gene.2021.146134 · Cited by 149
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
Cabral-Marques, O., Halpert, G., Schimke, L. F., Ostrinski, Y., Vojdani, A., Baiocchi, G. C., Freire, P. P., Filgueiras, I. S., Zyskind, I., Lattin, M. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28905-5 · Cited by 144
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
Zhang, J., Cai, Y., Lavine, C. L., Peng, H., Zhu, H., Anand, K., Tong, P., Gautam, A. K., Mayer, M. L., Rits‐Volloch, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110729 · Cited by 145
Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection
Trottein, F., & Sokol, H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107915 · Cited by 141
Collin, J., Queen, R. A., Zerti, D., Dorgau, B., Γεωργίου, Μ., Djidrovski, I., Hussain, R., Coxhead, J., Joseph, A., Rooney, P., et al. (2020) · The Ocular Surface · doi:10.1016/j.jtos.2020.05.013 · Cited by 143
Self-citationA compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I. O., Akdiş, M., Alves‐Correia, M., Antó, J. M., Arcolacı, A., Azkur, A. K., Azkur, D., et al. (2020) · Allergy · doi:10.1111/all.14449 · Cited by 140
Nasal ACE2 Levels and COVID-19 in Children
Patel, A. B., & Verma, A. (2020) · JAMA · doi:10.1001/jama.2020.8946 · Cited by 143
Wong, N. A., & Saier, M. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031308 · Cited by 144
Camostat mesylate against SARS‐CoV‐2 and COVID‐19—Rationale, dosing and safety
Breining, P., Frølund, A. L., Højen, J. F., Gunst, J. D., Stærke, N. B., Sædder, E. A., Cases, M., Little, P. S., Nielsen, L. P., Søgaard, O. S., et al. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13533 · Cited by 141
Anosmia in COVID-19: Mechanisms and Significance
Han, A. Y., Mukdad, L. A., Long, J. L., & López, I. A. (2020) · Chemical Senses · doi:10.1093/chemse/bjaa040 · Cited by 139
COVID-19 and Alzheimer’s disease: how one crisis worsens the other
Xia, X., Wang, Y., & Zheng, J. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00237-2 · Cited by 138
Baig, A. M., & Sanders, E. C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26105 · Cited by 138
ACE2: the molecular doorway to SARS-CoV-2
Medina-Enríquez, M. M., López‐León, S., Carlos-Escalante, J. A., Torres, Z. A., Cuapio, A., & Wegman-Ostrosky, T. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00519-8 · Cited by 136
Vietzen, H., Zoufaly, A., Traugott, M. T., Aberle, J. H., Aberle, S. W., & Puchhammer‐Stöckl, E. (2021) · Genetics in Medicine · doi:10.1038/s41436-020-01077-7 · Cited by 134
Sex‐based differences in severity and mortality in COVID‐19
Alwani, M. M., Yassin, A. A., Al‐Zoubi, R. M., Aboumarzouk, O. M., Nettleship, J. E., Kelly, D. M., Al-Qudimat, A. R., & Shabsigh, R. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2223 · Cited by 139
From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
Michalski, J. E., Kurche, J. S., & Schwartz, D. A. (2021) · Translational research · doi:10.1016/j.trsl.2021.09.001 · Cited by 139
The immuno-oncological challenge of COVID-19
Derosa, L., Melenotte, C., Griscelli, F., Gachot, B., Marabelle, A., Kroemer, G., & Zitvogel, L. (2020) · Nature Cancer · doi:10.1038/s43018-020-00122-3 · Cited by 136
King, R. G., Silva-Sánchez, A., Peel, J. N., Botta, D., Dickson, A. M., Pinto, A. K., Meza‐Perez, S., Allie, S. R., Schultz, M. D., Liu, M., et al. (2021) · Vaccines · doi:10.3390/vaccines9080881 · Cited by 134
Biering, S. B., Sarnik, S. A., Wang, E., Zengel, J. R., Leist, S. R., Schäfer, A., Sathyan, V., Hawkins, P., Okuda, K., Tau, C., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01131-x · Cited by 137
Schuler, B. A., Habermann, A. C., Plosa, E. J., Taylor, C. J., Jetter, C. S., Kapp, M., Benjamin, J. T., Gulleman, P., Nichols, D. S., Braunstein, L. Z., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140766 · Cited by 136
Self-citationSex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger?
Pivonello, R., Auriemma, R. S., Pivonello, C., Isidori, A. M., Corona, G., Colao, A. A. L., & Millar, R. P. (2020) · Neuroendocrinology · doi:10.1159/000513346 · Cited by 134
The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19
Schreiber, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.595739 · Cited by 136
Damialis, A., Gilles, S., Sofiev, M. A., Sofieva, V., Kolek, F., Bayr, D., Plaza, M. P., Leier-Wirtz, V., Kaschuba, S., Ziska, L. H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019034118 · Cited by 135
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
Puray‐Chavez, M., LaPak, K. M., Schrank, T. P., Elliott, J. L., Bhatt, D. P., Agajanian, M. J., Jasuja, R., Lawson, D. Q., Davis, K., Rothlauf, P. W., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109364 · Cited by 139
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Oudit, G. Y., Wang, K., Viveiros, A., Kellner, M. J., & Penninger, J. M. (2023) · Cell · doi:10.1016/j.cell.2023.01.039 · Cited by 136
COVID‐19 and cutaneous manifestations: a systematic review
Zhao, Q. S., Fang, X., Pang, Z., Zhang, B., Liu, H., & Zhang, F. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16778 · Cited by 130
Beneficial Properties of Bromelain
Hikisz, P., & Bernasinska-Slomczewska, J. (2021) · Nutrients · doi:10.3390/nu13124313 · Cited by 142
Wei, Y., & Shah, R. (2020) · Pharmaceuticals · doi:10.3390/ph13070155 · Cited by 140
Covid-19-Associated Retinopathy: A Case Report
Gascon, P., Briantais, A., Bertrand, E., Ramtohul, P., Comet, A., Beylerian, M., Sauvan, L., Swiader, L., Durand, J. M., & Denis, D. (2020) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2020.1825751 · Cited by 129
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Pathania, A. S., Prathipati, P., Abdul, B. A., Chava, S. P., Katta, S. S., Gupta, S. C., Gangula, P. R., Pandey, M. K., Durden, D. L., Byrareddy, S. N., et al. (2020) · Theranostics · doi:10.7150/thno.51471 · Cited by 131
Phosphatidylserine receptors enhance SARS-CoV-2 infection
Bohan, D., Ert, H. A. V., Ruggio, N., Rogers, K. J., Badreddine, M., Aguilar-Briseño, J. A., Elliff, J. M., Chávez, R. A. R., Gao, B., Stokowy, T., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009743 · Cited by 132
Impact of COVID-19 on Cardiovascular Disease
Vosko, I., Zirlik, A., & Bugger, H. (2023) · Viruses · doi:10.3390/v15020508 · Cited by 139
Recent advances in lung organoid development and applications in disease modeling
Vazquez‐Armendariz, A. I., & Tata, P. R. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170500 · Cited by 136
Gkogkou, E., Barnasas, G., Vougas, K. N., & Trougakos, I. P. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101615 · Cited by 134
Multi-species single-cell transcriptomic analysis of ocular compartment regulons
Gautam, P., Hamashima, K., Chen, Y., Zeng, Y., Makovoz, B., Parikh, B. H., Lee, H. Y., Lau, K. A., Su, X., Wong, R. C. B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25968-8 · Cited by 128
Sienkiewicz, M., Jaśkiewicz, A., Tarasiuk, A., & Fichna, J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1895063 · Cited by 127
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Farahani, M., Niknam, Z., Amirabad, L. M., Dashatan, N. A., Koushki, M., Nemati, M., Pouya, F. D., Rezaei–Tavirani, M., Rasmi, Y., & Tayebi, L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112420 · Cited by 126
Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19
Senapati, S., Banerjee, P., Bhagavatula, S., Kushwaha, P. P., & Kumar, S. (2021) · Journal of Genetics · doi:10.1007/s12041-021-01262-w · Cited by 127
Laporte, M., Raeymaekers, V., Berwaer, R. V., Vandeput, J., Marchand-Casas, I., Thibaut, H. J., Looveren, D. V., Martens, K., Hoffmann, M., Maes, P., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009500 · Cited by 126
Hatton, C. F., Botting, R. A., Dueñas, M. E., Haq, I., Verdon, B., Thompson, B. J., Spegarova, J. S., Gothe, F., Stephenson, E., Gardner, A. I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27318-0 · Cited by 125
Ashary, N., Bhide, A., Chakraborty, P., Colaco, S., Mishra, A., Chhabria, K., Jolly, M. K., & Modi, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00783 · Cited by 121
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings
Williams, P. C. M., Howard‐Jones, A. R., Hsu, P. S., Palasanthiran, P., Gray, P. E., McMullan, B. J., Britton, P. N., & Bartlett, A. W. (2020) · Pathology · doi:10.1016/j.pathol.2020.08.001 · Cited by 125
SARS-CoV-2 Invades the Central Nervous System via the Olfactory Route in Rhesus Monkeys
Li, J., Yang, Y., Yu, W., Zhao, Y., Long, H., Gao, J., Ding, K., Ma, C., Li, J., Zhao, S., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00591-7 · Cited by 126
Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data
Hu, J., Li, C., Wang, S., Li, T., & Zhang, H. (2021) · Human Genomics · doi:10.1186/s40246-021-00306-7 · Cited by 122
Asthma and COVID-19: an update
Adir, Y., Saliba, W., Beurnier, A., & Humbert, M. J. C. (2021) · European Respiratory Review · doi:10.1183/16000617.0152-2021 · Cited by 120
The ocular surface, coronaviruses and COVID‐19
Willcox, M. D. P., Walsh, K., Nichols, J. J., Morgan, P. B., & Jones, L. (2020) · Clinical and Experimental Optometry · doi:10.1111/cxo.13088 · Cited by 122
Nanofiber-Based Face Masks and Respirators as COVID-19 Protection: A Review
Essa, W. K., Yasin, S. A., Saeed, I. A., & Ali, G. A. M. (2021) · Membranes · doi:10.3390/membranes11040250 · Cited by 119
Meng, Z., Wang, T., Chen, L., Chen, X., Li, L., Qin, X., Li, H., & Luo, J. D. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666210429083050 · Cited by 119
Wang, P., Luo, R., Zhang, M., Wang, Y., Song, T., Tao, T., Li, Z., Jin, L., Zheng, H., Chen, W., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03252-9 · Cited by 118
Flaumenhaft, R. C., Enjyoji, K., & Schmaier, A. A. (2022) · Blood · doi:10.1182/blood.2021012250 · Cited by 121
Single-cell transcriptomics for the assessment of cardiac disease
Miranda, A. M. A., Janbandhu, V., Maatz, H., Kanemaru, K., Cranley, J., Teichmann, S. A., Hübner, N., Schneider, M. D., Harvey, R. P., & Noseda, M. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00805-7 · Cited by 117
Self-citationSong, X., Hu, W., Yu, H., Zhao, L., Zhao, Y., Zhao, X., Xue, H., & Zhao, Y. (2023) · Cytometry Part A · doi:10.1002/cyto.a.24285 · Cited by 117
(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117
Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
Zhang, L., & Guo, H. (2020) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2020.08.001 · Cited by 118
Yousefi, H., Mashouri, L., Okpechi, S. C., Alahari, N. V., & Alahari, S. K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114296 · Cited by 117
He, L., Mäe, M. A., Muhl, L., Sun, Y., Pietilä, R., Nahar, K., Liébanas, E. V., Fagerlund, M. J., Oldner, A., Liu, J., et al. (2020) · doi:10.1101/2020.05.11.088500 · Cited by 116
Defensive Properties of Mucin Glycoproteins during Respiratory Infections—Relevance for SARS-CoV-2
Chatterjee, M., van Putten, J. P. M., & Strijbis, K. (2020) · mBio · doi:10.1128/mbio.02374-20 · Cited by 116
Dissecting lipid metabolism alterations in SARS-CoV-2
Casari, I., Manfredi, M., Metharom, P., & Falasca, M. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101092 · Cited by 120
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients
Maio, F. D., Posteraro, B., Ponziani, F. R., Cattani, P., Gasbarrini, A., & Sanguinetti, M. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00131-7 · Cited by 116
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2
Hekman, R. M., Hume, A. J., Goel, R. K., Abo, K. M., Huang, J., Blum, B. C., Werder, R. B., Suder, E. L., Paul, I., Phanse, S., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.11.028 · Cited by 115
Impact of climate and ambient air pollution on the epidemic growth during COVID-19 outbreak in Japan
Azuma, K., Kagi, N., Kim, H., & Hayashi, M. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110042 · Cited by 113
Pathological findings in organs and tissues of patients with COVID-19: A systematic review
Peiris, S., Mesa, H. A., Aysola, A. E., Manivel, J. C., Toledo, J., Borges-Sa, M., Aldighieri, S., & Revéiz, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250708 · Cited by 117
Amraei, R., Xia, C., Olejnik, J., White, M. R., Napoleon, M. A., Lotfollahzadeh, S., Hauser, B. M., Schmidt, A. G., Chitalia, V. C., Mühlberger, E., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113874119 · Cited by 113
Hopfer, H., Herzig, M. C., Gosert, R., Menter, T., Hench, J., Tzankov, A., Hirsch, H. H., & Miller, S. (2020) · Histopathology · doi:10.1111/his.14264 · Cited by 113
Cell type ontologies of the Human Cell Atlas
Osumi-Sutherland, D., Xu, C., Keays, M., Levine, A. P., Kharchenko, P. V., Regev, A., Lein Ed, S., & Teichmann, S. A. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00787-7 · Cited by 118
Time course of anosmia and dysgeusia in patients with mild SARS-CoV-2 infection
Levinson, R., Elbaz, M., Ben‐Ami, R., Shasha, D., Levinson, T., Choshen, G., Petrov, K., Gadoth, A., & Paran, Y. (2020) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2020.1772992 · Cited by 111
Advances in research on ACE2 as a receptor for 2019-nCoV
Wu, J., Deng, W., Li, S., & Yang, X. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03611-x · Cited by 114
Yassin, A., Nawaiseh, M. B., Shaban, A., Alsherbini, K. A., El‐Salem, K., Soudah, O., & Abu-Rub, M. (2021) · BMC Neurology · doi:10.1186/s12883-021-02161-4 · Cited by 109
Campione, E., Cosio, T., Rosa, L., Lanna, C., Girolamo, S. D., Gaziano, R., Valenti, P., & Bianchi, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144903 · Cited by 110
Targeting Proteases for Treating COVID-19
Luan, B., Huynh, T., Cheng, X. M., Lan, G., & Wang, H. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00430 · Cited by 109
Wang, P., Jin, L., Zhang, M., Wu, Y., Duan, Z., Guo, Y., Wang, C., Guo, Y., Chen, W., Liao, Z., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01054-w · Cited by 116
The Ocular Surface and the Coronavirus Disease 2019: Does a Dual ‘Ocular Route’ Exist?
Napoli, P. E., Nioi, M., d’Aloja, E., & Fossarello, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051269 · Cited by 107
SARS‐CoV‐2‐specific virulence factors in COVID‐19
Kumar, A., Prasoon, P., Kumari, C., Pareek, V., Faiq, M. A., Narayan, R. K., Kulandhasamy, M., & Kant, K. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26615 · Cited by 112
Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut
Triana, S., Metz‐Zumaran, C., Ramírez, C. D., Kee, C., Doldan, P., Shahraz, M., Schraivogel, D., Gschwind, A. R., Sharma, A. K., Steinmetz, L. M., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110232 · Cited by 111
Gamage, A. M., Tan, K. S., Chan, W. O. Y., Liu, J., Tan, C. W., Ong, Y. K., Thong, M. K. T., Andiappan, A. K., Anderson, D. E., Wang, D. Y., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009130 · Cited by 107
The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
Morris, G., Bortolasci, C. C., Puri, B. K., OLIVE, L. S., Marx, W., O'Neil, A. E., Athan, E., Carvalho, A. F., Maes, M. H. J., Walder, K. R., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118166 · Cited by 107
COVID-19, cytokines, inflammation, and spices: How are they related?
Kunnumakkara, A. B., Rana, V., Parama, D., Banik, K., Girisa, S., Henamayee, S., Thakur, K. K., Dutta, U., Garodia, P., Gupta, S. C., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119201 · Cited by 107
The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2
Chow, R. D.-W., Majety, M., & Chen, S. (2021) · Nature Communications · doi:10.1038/s41467-020-20323-9 · Cited by 106
Fiege, J. K., Thiede, J. M., Nanda, H. A., Matchett, W. E., Moore, P. J., Montanari, N. R., Thielen, B. K., Daniel, J. J., Stanley, E., Hunter, R. C., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009292 · Cited by 108
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Degenhardt, F. C., Ellinghaus, D., Juzėnas, S., Lerga-Jaso, J., Wendorff, M., Maya‐Miles, D., Uellendahl-Werth, F., ElAbd, H., Rühlemann, M. C., Arora, J., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac158 · Cited by 107
Singh, H., Choudhari, R. H., Nema, V., & Khan, A. A. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104621 · Cited by 106
Nersisyan, S. A., Shkurnikov, M. Y., Turchinovich, A. A., Knyazev, E. N., & Tonevitsky, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235987 · Cited by 103
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
Saponaro, F., Rutigliano, G., Sestito, S., Bandini, L., Storti, B., Bizzarri, R., & Zucchi, R. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.588618 · Cited by 106
COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences
Martínez-Salazar, B., Holwerda, M., Stüdle, C., Piragyte, I., Mercader, N., Engelhardt, B., Rieben, R., & Döring, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.824851 · Cited by 106
SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune ReceptorsPreprint
Gao, C., Zeng, J., Jia, N., Stavenhagen, K., Matsumoto, Y., Zhang, H., Jiang, L., Hume, A. J., Mühlberger, E., van Die, I., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.29.227462 · Cited by 105
SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping
Kaur, G., Lungarella, G., & Rahman, I. (2020) · Journal of Inflammation · doi:10.1186/s12950-020-00250-8 · Cited by 102
Wicik, Z., Eyileten, C., Jakubik, D., Simões, S. N., Martins, D., Pavão, R., Siller-Matula, J. M., & Postula, M. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113743 · Cited by 100
The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19
An, X., Zhang, Y., Duan, L., Jin, D., Zhao, S., Zhou, R., Duan, Y., Lian, F., & Tong, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111267 · Cited by 101
Zhang, Z., Cui, F., Cao, C., Wang, Q., & Zou, Q. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.105092 · Cited by 101
Morrison, C. B., Edwards, C. E., Shaffer, K. M., Araba, K. C., Wykoff, J. A., Williams, D. R., Asakura, T., Dang, H., Morton, L. C., Gilmore, R. C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119680119 · Cited by 107
Pasquarelli-do-Nascimento, G., Braz-de-Melo, H. A., Faria, S. S., Santos, I. D. O., Kobinger, G., & Magalhães, K. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00530 · Cited by 103
LePendu, J., Breiman, A., Rocher, J., Dion, M., & Ruvoën‐Clouet, N. (2021) · Viruses · doi:10.3390/v13020160 · Cited by 102
Fröberg, J., Gillard, J., Philipsen, R. L. A., Lanke, K. H. W., Rust, J., van Tuijl, D., Teelen, K., Bousema, T., Simonetti, E. R., Jongh, C. E. V. D. G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25949-x · Cited by 105
Long-Term Modeling of SARS-CoV-2 Infection of In Vitro Cultured Polarized Human Airway Epithelium
Hao, S., Ning, K., Küz, Ç. A., Vorhies, K., Yan, Z., & Qiu, J. (2020) · mBio · doi:10.1128/mbio.02852-20 · Cited by 102
Proud, P. C., Tsitoura, D. C., Watson, R. J., Chua, B. Y. L., Aram, M. J., Bewley, K. R., Cavell, B. E., Cobb, R., Dowall, S., Fotheringham, S. A., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103153 · Cited by 98
Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era
Frank, S., Capriotti, J. A., Brown, S. M., & Tessema, B. (2020) · Ear Nose & Throat Journal · doi:10.1177/0145561320932318 · Cited by 97
Yao, Q., Cheng, S., Pan, Q., Yu, J., Cao, G., Li, L., & Cao, H. (2024) · MedComm · doi:10.1002/mco2.735 · Cited by 100
Thoughts on the alveolar phase of COVID-19
Mason, R. J. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00126.2020 · Cited by 98
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
An, X., Martinez-Paniagua, M. A., Rezvan, A., Sefat, S. R., Fathi, M., Singh, S., Biswas, S., Pourpak, M., Yee, C., Liu, X., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103037 · Cited by 98
Prasad, K., Khatoon, F., Rashid, S., Ali, N., Alasmari, A. F., Ahmed, M. Z., Alqahtani, A. S., Alqahtani, M. S., & Kumar, V. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.228 · Cited by 96
Metadata
- Authors
- HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., Sampaziotis, F., Worlock, K. B., Yoshida, M., & Barnes, J. L.
- Affiliations
- Wellcome Sanger Institute (GB)
- Centre National de la Recherche Scientifique (FR)
- University Medical Center Groningen (NL)
- Max Delbrück Center (DE)
- Harvard University (US)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- University College London (GB)
- Corresponding author
- Sungnak, Waradon
- ORCID
- Venue
- Nature Medicine
- Published
- 2020-04-23
- Volume
- 26
- Issue
- 5
- Pages
- 681-687
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC8637938
- OpenAlex
- W3011483298
- Cited by
- 2,501
- References
- 59
- Citations by year
- 2026: 53 · 2025: 105 · 2024: 140 · 2023: 265 · 2022: 454 · 2021: 814 · 2020: 664
- FWCI
- 71.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- PubMed Central (acceptedVersion)
- arXiv (Cornell University) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion, public-domain)
- Apollo (University of Cambridge) (submittedVersion)
- HAL (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Site cant be reached (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Defense (W81XWH1910416)
- Howard Hughes Medical Institute
- U.S. Department of Veterans Affairs
- Bill and Melinda Gates Foundation
- Richard and Susan Smith Family Foundation
- Massachusetts General Hospital
- Yale University
- Vanderbilt University
- Massachusetts Institute of Technology
- Memorial Sloan-Kettering Cancer Center
- Northwestern University
- School of Medicine, Boston University
- Arizona State University
- Helsingin Yliopisto
- University of Washington
- Deutsches Zentrum für Infektionsforschung
- Wellcome Trust (211276/Z/18/Z, 211276/D/18/Z, 108082/A/15/Z, #MR/R006237/1, WT206194, 107931/Z/15/Z, GINOP-2.3.2-15-2016-00026, WT211276/Z/18/Z)
- Deutsches Zentrum für Herz-Kreislaufforschung
- European Bioinformatics Institute
- National Jewish Health
- Vanderbilt University Medical Center
- European Molecular Biology Laboratory
- Broad Institute
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- Manton Foundation
- University of Alberta
- Cancer Research UK
- National Institute for Health and Care Research (PB-PG-1215-20037, CL-2017-14-001)
- British Heart Foundation (SP/19/1/34461, PG/16/47/32156)
- Cystic Fibrosis Trust (VIA 028)
- Academy of Medical Sciences (SGL019\1071)
- Imperial College London (H2020)
- University College London
- Newcastle University
- European Commission (2018-342, GINOP‐2.3.2‐15‐2016‐00037, 874656, GINOP-2.3.2-15-2016-00006, H2020)
- Rosetrees Trust
- National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/T2T0419, NC/N001540/1)
- National Research Foundation
- Deutsche Forschungsgemeinschaft (347286815, DK043351, EXC2151/1, EXC 2151, 329123747, 390873048)
- Agence Nationale de la Recherche (ANR‐10‐INBS‐09‐03, ANR- 10-INBS-09, ANR‐19, ANR-19-CE14, ANR-19-CE14-0027, ANR-10, 10-INBS-09, -15-IDEX-01, ANR‐15‐IDEX‐01)
- Fondation Leducq
- Rijksuniversiteit Groningen
- University of New South Wales
- National Natural Science Foundation of China (31871370)
- Catholic University of Korea
- Cancerfonden (2019-)
- Fondation pour la Recherche Médicale (DEQ20180339158)
- National Research Foundation of Korea
- Karolinska Institutet
- National Science and Technology Development Agency
- Kungliga Tekniska Högskolan
- Vetenskapsrådet (2018-)
- Thailand Research Fund
- Centre National de la Recherche Scientifique
- Universitair Medisch Centrum Groningen
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Medizinischen Hochschule Hannover
- Rheinische Friedrich-Wilhelms-Universität Bonn
- Stockholms Universitet
- Science for Life Laboratory
- Conseil Départemental des Alpes Maritimes (2016-294DGADSH-CV)
- Deutsches Zentrum für Lungenforschung
- National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/N001540/1)
- Ministerie van Economische Zaken en Klimaat
- Berlin Institute of Health
- National Institutes of Health (1r56hl135124-01, H2020, AG‐049665, DK 043351, AI135964)
- Directorate for Biological Sciences
- School of Medicine, Duke University
- School of Medicine, Stanford University
- University of California, San Diego
- Harvard Stem Cell Institute
- Feinberg School of Medicine
- Medical School, University of Michigan
- Horizon 2020 Framework Programme (874656, GINOP-2.3.2)
- Klarman Cell Observatory, Broad Institute
- Medical Research Council (MC_PC_17230, MR/R015635/1, MR/P009581/1, MC_PC_12009, MR/R006237/1, MR/K017047/1, MR/S005579/1)
- Engineering and Physical Sciences Research Council (TS/H001220/1)
- Biotechnology and Biological Sciences Research Council (BB/T004460/1, BB/V01126X/1)
- National Health and Medical Research Council
- Faculty of Medical Sciences, Newcastle University
- European Regional Development Fund (GINOP‐2.3.2‐15‐2016‐00006, H2020, GINOP-2.3.2-15-2016-00037, GINOP-2.3.2-15-2016-00026)
- NIHR Newcastle Biomedical Research Centre
- Helmholtz Zentrum München
- NIHR Cambridge Biomedical Research Centre
- National Institute on Aging (P01AG049665)
- National Heart, Lung, and Blood Institute (HL135124, R01HL146557, U01HL148856, R56 HL135124, K08HL130595, K08HL146943, HL148856, U01HL145567, R01HL145372, R01HL127349)
- National Institute of Allergy and Infectious Diseases (U24AI118672, U19AI135964)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD000836)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Keywords
- SARS-CoV-2, viral entry factors, ACE2, TMPRSS2, nasal epithelial cells, innate immunity, respiratory epithelium, corneal epithelium, intestinal epithelium, tissue tropism, COVID-19 pandemic, single-cell transcriptomics, gene co-expression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
